383 related articles for article (PubMed ID: 29370234)
1. Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.
Madhi F; Jung C; Timsit S; Levy C; Biscardi S; Lorrot M; Grimprel E; Hees L; Craiu I; Galerne A; Dubos F; Cixous E; Hentgen V; Béchet S; ; Bonacorsi S; Cohen R
PLoS One; 2018; 13(1):e0190910. PubMed ID: 29370234
[TBL] [Abstract][Full Text] [Related]
2. Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study.
Lignieres G; Birgy A; Jung C; Bonacorsi S; Levy C; Angoulvant F; Grimprel E; Dommergues MA; Gillet Y; Craiu I; Rybak A; De Pontual L; Dubos F; Cixous E; Gajdos V; Pinquier D; Andriantahina I; Soussan-Banini V; Georget E; Launay E; Vignaud O; Cohen R; Madhi F
PLoS One; 2021; 16(9):e0257217. PubMed ID: 34529722
[TBL] [Abstract][Full Text] [Related]
3. Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
Lagree M; Bontemps S; Dessein R; Angoulvant F; Madhi F; Martinot A; Cohen R; Dubos F;
Med Mal Infect; 2018 May; 48(3):193-201. PubMed ID: 29449049
[TBL] [Abstract][Full Text] [Related]
4. Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia.
Abera B; Kibret M; Mulu W
PLoS One; 2016; 11(11):e0166519. PubMed ID: 27846254
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysis.
Flokas ME; Detsis M; Alevizakos M; Mylonakis E
J Infect; 2016 Dec; 73(6):547-557. PubMed ID: 27475789
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Asakura T; Ikeda M; Nakamura A; Kodera S
Int J Infect Dis; 2014 Dec; 29():91-5. PubMed ID: 25461239
[TBL] [Abstract][Full Text] [Related]
7. Community-Onset Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France.
Toubiana J; Timsit S; Ferroni A; Grasseau M; Nassif X; Lortholary O; Zahar JR; Chalumeau M
Medicine (Baltimore); 2016 Mar; 95(12):e3163. PubMed ID: 27015202
[TBL] [Abstract][Full Text] [Related]
8. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
[TBL] [Abstract][Full Text] [Related]
9. Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae.
Kim SA; Altshuler J; Paris D; Fedorenko M
Int J Antimicrob Agents; 2018 Jan; 51(1):155-158. PubMed ID: 28943367
[TBL] [Abstract][Full Text] [Related]
10. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
Raja NS
J Infect Public Health; 2019; 12(6):843-846. PubMed ID: 31176606
[TBL] [Abstract][Full Text] [Related]
11. International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: A case-case-control study in an urban U.S. hospital.
Strysko JP; Mony V; Cleveland J; Siddiqui H; Homel P; Gagliardo C
Travel Med Infect Dis; 2016; 14(6):568-571. PubMed ID: 27890813
[TBL] [Abstract][Full Text] [Related]
12. Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
Dalgic N; Sancar M; Bayraktar B; Dincer E; Pelit S
Scand J Infect Dis; 2011 May; 43(5):339-43. PubMed ID: 21271945
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of inappropriate antibiotic therapy for upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a retrospective cohort study.
Greenhouse I; Babushkin F; Finn T; Shimoni Z; Aliman M; Ben-Ami R; Cohen R
Diagn Microbiol Infect Dis; 2017 Nov; 89(3):222-229. PubMed ID: 28865741
[TBL] [Abstract][Full Text] [Related]
14. Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013.
Arnaud I; Maugat S; Jarlier V; Astagneau P;
Euro Surveill; 2015; 20(36):. PubMed ID: 26536042
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and treatment strategies of febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: a multicenter retrospective observational study in Japan.
Ohnishi T; Mishima Y; Naito T; Matsuda N; Ariji S; Umino D; Tamura K; Nishimoto H; Kinoshita K; Maeda N; Kawaguchi A; Yonezawa R; Mimura S; Fukushima H; Nanao K; Yoshida M; Sekijima T; Kamimaki I
Int J Infect Dis; 2022 Dec; 125():97-102. PubMed ID: 36180033
[TBL] [Abstract][Full Text] [Related]
16. ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence.
Pilmis B; Scemla A; Join-Lambert O; Mamzer MF; Lortholary O; Legendre C; Zahar JR
Infect Dis (Lond); 2015; 47(10):714-8. PubMed ID: 26024285
[TBL] [Abstract][Full Text] [Related]
17. Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017.
Birgy A; Madhi F; Jung C; Levy C; Cointe A; Bidet P; Hobson CA; Bechet S; Sobral E; Vuthien H; Ferroni A; Aberrane S; Cuzon G; Beraud L; Gajdos V; Launay E; Pinquier D; Haas H; Desmarest M; Dommergues MA; Cohen R; Bonacorsi S;
J Antimicrob Chemother; 2020 Jan; 75(1):96-105. PubMed ID: 31617912
[TBL] [Abstract][Full Text] [Related]
18. Clinical Features of Febrile Urinary Tract Infection Caused by Extended-spectrum Beta-lactamase-producing Escherichia Coli in Children.
Ohnishi T; Mishima Y; Takizawa S; Tsutsumi K; Amemiya A; Akiyama N; Kanna Y; Asato S; Tomita M; Ikemiyagi M; Shikoro N; Nakazawa M; Kurihara N; Kamimaki I
Keio J Med; 2020 Jun; 69(2):43-47. PubMed ID: 31474677
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Febrile Urinary Tract Infection Caused by ESBL Producing
Agegnehu A; Worku M; Nigussie D; Lulu B; Tadesse BT
Biomed Res Int; 2020; 2020():6679029. PubMed ID: 34692824
[TBL] [Abstract][Full Text] [Related]
20. [Urinary Tract Infections Caused by Community-Acquired Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in a Level III Hospital - A Retrospective Study].
Simões A; Lima M; Brett A; Queiroz C; Chaves C; Oliveira H; Januário L; Rodrigues F
Acta Med Port; 2020 Jul; 33(7-8):466-474. PubMed ID: 31962058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
